ATE508115T1 - Kristalline formen von 4-ä2-(4- methylphenylsulfanyl)phenylüpiperidin mit kombinierter serotonin- und norepinephrinwiederaufnahmehemmung zur behandlung neuropathischer schmerzen - Google Patents
Kristalline formen von 4-ä2-(4- methylphenylsulfanyl)phenylüpiperidin mit kombinierter serotonin- und norepinephrinwiederaufnahmehemmung zur behandlung neuropathischer schmerzenInfo
- Publication number
- ATE508115T1 ATE508115T1 AT07764496T AT07764496T ATE508115T1 AT E508115 T1 ATE508115 T1 AT E508115T1 AT 07764496 T AT07764496 T AT 07764496T AT 07764496 T AT07764496 T AT 07764496T AT E508115 T1 ATE508115 T1 AT E508115T1
- Authority
- AT
- Austria
- Prior art keywords
- reuppost
- phenylupiperidine
- methylphenylsulfanyl
- norepinephrine
- inhibition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/08—Malonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
- C07C55/02—Dicarboxylic acids
- C07C55/12—Glutaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80500906P | 2006-06-16 | 2006-06-16 | |
DKPA200600816 | 2006-06-16 | ||
DKPA200700423 | 2007-03-20 | ||
PCT/DK2007/050076 WO2007144006A1 (en) | 2006-06-16 | 2007-06-15 | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE508115T1 true ATE508115T1 (de) | 2011-05-15 |
Family
ID=39722478
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT07764496T ATE508115T1 (de) | 2006-06-16 | 2007-06-15 | Kristalline formen von 4-ä2-(4- methylphenylsulfanyl)phenylüpiperidin mit kombinierter serotonin- und norepinephrinwiederaufnahmehemmung zur behandlung neuropathischer schmerzen |
Country Status (15)
Country | Link |
---|---|
JP (1) | JP2014098017A (ja) |
KR (1) | KR101472595B1 (ja) |
AR (1) | AR061480A1 (ja) |
AT (1) | ATE508115T1 (ja) |
BR (1) | BRPI0712758A2 (ja) |
CA (1) | CA2784304A1 (ja) |
DE (1) | DE602007014372D1 (ja) |
DK (1) | DK2044020T3 (ja) |
MY (1) | MY150698A (ja) |
NZ (1) | NZ572856A (ja) |
PT (1) | PT2044020E (ja) |
RS (1) | RS51687B (ja) |
SI (1) | SI2044020T1 (ja) |
TN (1) | TNSN08461A1 (ja) |
TW (1) | TWI444365B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101972931B1 (ko) | 2017-10-19 | 2019-04-26 | 재단법인대구경북과학기술원 | 풍선 타입 피질전도 측정장치 및 이의 제조방법 |
CN116930385B (zh) * | 2023-08-08 | 2024-02-20 | 北京爱思益普生物科技股份有限公司 | 一种高盐浓度制剂中化合物浓度的测定方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA81749C2 (uk) * | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
EP2044020B1 (en) * | 2006-06-16 | 2011-05-04 | H. Lundbeck A/S | Crystalline forms of 4- [2- (4-methylphenylsulfanyl) -phenyl]piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of neuropathic pain |
-
2007
- 2007-06-15 CA CA2784304A patent/CA2784304A1/en not_active Abandoned
- 2007-06-15 AT AT07764496T patent/ATE508115T1/de active
- 2007-06-15 AR ARP070102640A patent/AR061480A1/es unknown
- 2007-06-15 RS RS20110223A patent/RS51687B/en unknown
- 2007-06-15 SI SI200730594T patent/SI2044020T1/sl unknown
- 2007-06-15 NZ NZ572856A patent/NZ572856A/en not_active IP Right Cessation
- 2007-06-15 BR BRPI0712758-8A patent/BRPI0712758A2/pt not_active IP Right Cessation
- 2007-06-15 DE DE602007014372T patent/DE602007014372D1/de active Active
- 2007-06-15 PT PT07764496T patent/PT2044020E/pt unknown
- 2007-06-15 MY MYPI20084894 patent/MY150698A/en unknown
- 2007-06-15 DK DK07764496.1T patent/DK2044020T3/da active
- 2007-06-20 TW TW096121999A patent/TWI444365B/zh not_active IP Right Cessation
-
2008
- 2008-11-17 TN TNP2008000461A patent/TNSN08461A1/en unknown
- 2008-12-11 KR KR1020087030260A patent/KR101472595B1/ko not_active IP Right Cessation
-
2014
- 2014-02-03 JP JP2014018411A patent/JP2014098017A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MY150698A (en) | 2014-02-28 |
JP2014098017A (ja) | 2014-05-29 |
RS51687B (en) | 2011-10-31 |
DE602007014372D1 (de) | 2011-06-16 |
PT2044020E (pt) | 2011-05-12 |
NZ572856A (en) | 2012-02-24 |
TW200817329A (en) | 2008-04-16 |
TNSN08461A1 (en) | 2010-04-14 |
DK2044020T3 (da) | 2011-08-15 |
TWI444365B (zh) | 2014-07-11 |
KR101472595B1 (ko) | 2014-12-15 |
AR061480A1 (es) | 2008-08-27 |
KR20090018630A (ko) | 2009-02-20 |
SI2044020T1 (sl) | 2011-06-30 |
CA2784304A1 (en) | 2007-12-21 |
BRPI0712758A2 (pt) | 2012-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
DE502005010499D1 (de) | Implantat zur Behandlung von Fettsucht | |
ATE534633T1 (de) | Indazolderivate zur behandlung von hsp90- induzierten krankheiten | |
ATE438623T1 (de) | Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes | |
ATE490825T1 (de) | Behandlung von mineralschlämmen mit verbesserter pflanzenwachstumsrehabilitation | |
ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE550329T1 (de) | Heterobicyclische sulfonamidderivate zur behandlung von diabetes | |
ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
ATE512948T1 (de) | Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen | |
ATE545418T1 (de) | Zusammensetzungen und kits zur behandlung von influenza | |
EA201370208A1 (ru) | Формы рифаксимина и их применение | |
IL201309A0 (en) | Novel n - (8 - heteroaryltetrahydronaphtalene - 2yl) or n - (5 - heteroarylchromane - 3 - yl) carboxamide derivatives for the treatment of pain | |
DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
ATE493986T1 (de) | Diarylharnstoffe zur behandlung von pulmonaler hypertonie | |
ATE447551T1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
ATE532507T1 (de) | Neramexane zur behandlung von subakuten tinnitus | |
DE602006009899D1 (de) | Verwendung von oxycodon zur behandlung von viszeralem schmerz | |
DE602006013945D1 (de) | Substituierte cyclopentane oder cyclopentanone zur behandlung von augenhochdruck | |
DE502006007982D1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
ATE509621T1 (de) | Verwendung von 2,5-dihydroxybenzolderivaten zur behandlung von arthritis und schmerzen | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
DE112007001255A5 (de) | Tergurid/Protergurid zur Behandlung von chronischen Schmerzen | |
IL213703A0 (en) | Compounds and methods for the treatment of pain and other diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2044020 Country of ref document: EP |